30 1月 2020 by admin in UncategorizedComments TEMPEST THERAPEUTICS ANNOUNCES FDA CLEARANCE OF INVESTIGATIONAL NEW DRUG APPLICATION FOR TPST-1495 AND WELCOMES NEW INVESTORS
20 12月 2019 by admin in UncategorizedComments Syros Announces Appointment of Mark Alles to Its Board of Directors
18 12月 2019 by admin in UncategorizedComments GBT and Syros Partner to Discover, Develop and Commercialize Novel Therapies for Sickle Cell Disease and Beta Thalassemia
03 12月 2019 by admin in UncategorizedComments Centrexion Therapeutics Announces Issuance of U.S. Composition of Matter Patent for Lead Pipeline Candidate CNTX-4975
15 11月 2019 by admin in UncategorizedComments resTORbio Announces That the Phase 3 PROTECTOR 1 Trial of RTB101 in Clinically Symptomatic Respiratory Illness Did Not Meet the Primary Endpoint